Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Citi
Mallinckrodt
Merck
Fuji
Medtronic
Colorcon
Dow
US Army

Generated: April 26, 2018

DrugPatentWatch Database Preview

COGNEX Drug Profile

« Back to Dashboard

Which patents cover Cognex, and what generic alternatives are available?

Cognex is a drug marketed by Shionogi Inc and is included in one NDA.

The generic ingredient in COGNEX is tacrine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the tacrine hydrochloride profile page.
Drug patent expirations by year for COGNEX
Medical Subject Heading (MeSH) Categories for COGNEX
Synonyms for COGNEX
1,2,3,4-Tetrahydro-5-aminoacridine hydrochloride
1,2,3,4-Tetrahydro-9-acridinamine hydrochloride
1,2,3,4-Tetrahydro-9-acridinamine monohydrochloride
1,2,3,4-tetrahydro-9-acridinaminmonohydrochloride
1,2,3,4-Tetrahydro-9-aminoacridine hydrochloride
1,2,3,4-tetrahydroacridin-9-amine hydrochloride
1,2,3,4-Tetrahydroacridin-9-amine monohydrochloride
1,2,3,4-tetrahydroacridin-9-amine;hydrochloride
1,2,3,4-Tetrahydroacridin-9-aminehydrochloride
1684-40-8
2058AH
2739AH
321-64-2 (Parent)
4966RNG0BU
5,6,7,8-tetrahydroacridine-9-ylamine, chloride
9-Acridinamine, 1,2,3,4-tetrahydro-, monohydrochloride
9-Acridinamine,2,3,4,-tetrahydro-, monohydrochloride
9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE
9-amino-1,2,3,4-Tetrahydroacridine hydrochloride dihydrate
9-Amino-1,2,3,4-tetrahydroacridine monohydrochloride
A 3773
AC1MC3J3
ACRIDINE, 1,2,3,4-TETRAHYDRO-9-AMINO-, MONOHYDROCHLORIDE
Acridine, 9-amino-1,2,3,4-tetrahydro-, hydrochloride
Acridine, 9-amino-1,2,3,4-tetrahydro-, monohydrochloride (8CI)
Acridine,2,3,4-tetrahydro-, monohydrochloride
ACT08745
AK-60389
AKOS015913476
API0024823
AX8152331
B6527
BG0327
CAS-1684-40-8
CCG-39606
CCRIS 7250
CHEMBL1677
CI 970
CI-970
Cognex (TN)
CPD000059105
CTK8G3294
D02068
DSSTox_CID_6112
DSSTox_GSID_26112
DSSTox_RID_78021
DTXSID1026112
EINECS 216-867-5
EU-0100036
FT-0633768
Hydroaminacrine
I14-46547
J-010457
KB-216201
LP00036
MCULE-4824739637
MFCD00150067
MLS000028845
MLS000758202
MLS001401372
MolPort-001-683-425
NC00068
NCGC00024908-02
NCGC00093554-01
NCGC00093554-02
NCGC00093554-03
NCGC00093554-04
NCGC00257853-01
NCGC00260721-01
NSC 72108
NSC-72108
NSC-759324
NSC72108
NSC759324
Opera_ID_296
OROS-tacrine
Pharmakon1600-02300104
SAM001247002
SBB017537
SCHEMBL3270
SMR000059105
SPECTRUM2300104
SR-01000075593
SR-01000075593-16
ST50319524
T.H.A.
Tacrin hydrochloride
Tacrine HCl
Tacrine hydrochloride
Tacrine hydrochloride (USP)
Tacrine hydrochloride [USAN:USP]
Tacrine hydrochloride; THA hydrochloride
tacrine.HCl
Tenakrin
Tetrahydroaminoacridine Monohydrochloride
THA.HCl
Tox21_200299
Tox21_500036
TRA0055300
UNII-4966RNG0BU
ZUFVXZVXEJHHBN-UHFFFAOYSA-N

US Patents and Regulatory Information for COGNEX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-001 Sep 9, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-004 Sep 9, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-002 Sep 9, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-003 Sep 9, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for COGNEX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-004 Sep 9, 1993 ➤ Sign Up ➤ Sign Up
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-002 Sep 9, 1993 ➤ Sign Up ➤ Sign Up
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-002 Sep 9, 1993 ➤ Sign Up ➤ Sign Up
Shionogi Inc COGNEX tacrine hydrochloride CAPSULE;ORAL 020070-001 Sep 9, 1993 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Express Scripts
Fuji
AstraZeneca
Dow
Healthtrust
Covington
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.